INNOVIVA, INC. Other Nonoperating Expense
INNOVIVA, INC. (INVA) reported Other Nonoperating Expense of $2.63 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-31.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2018-10-31
- INNOVIVA, INC. other nonoperating expense for the quarter ending 2018-09-30 was $2.63M, a 58.77% decline year-over-year.
- INNOVIVA, INC. other nonoperating expense for the quarter ending 2017-09-30 was $6.37M.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 9 month |
|---|---|---|
| 2018-09-30 | $2.63M 10-Q · filed 2018-10-31 | $5.69M 10-Q · filed 2018-10-31 |
| 2017-09-30 | $6.37M 10-Q · filed 2018-10-31 | $7.11M 10-Q · filed 2018-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |